Trends in Skin Melanoma Burden: Findings From the Global Burden of Disease Study
- PMID: 35518191
- PMCID: PMC9038229
Trends in Skin Melanoma Burden: Findings From the Global Burden of Disease Study
Abstract
Background: Melanoma is the third most common skin cancer and the leading cause of skin cancer mortality. This study sought to investigate trends in melanoma incidence, mortality, and burden of disease.
Methods: The authors assessed the records of the Global Burden of Disease Study 2017 to extract information about the incidence, mortality, and disability adjusted life years (DALY) related to melanoma during 1990-2017 in the US and other countries based on their socio-demographic index (SDI).
Results: Melanoma incidence in the US increased 1.6 times, although the difference was not statistically significant. For patients over the age of 60, the incidence was significantly increased by 1.72 to 164.6 times. Mortality was relatively stable during the study period; however, it was increased for patients over 65 years of age (range: 1.03 to 70 times), although not statistically significant. Mortality-to-incidence ratio was decreased, but the difference was not statistically significant. For patients over 75 years of age, DALYs were statistically significantly increased by 1.34 to 1.71 times.
Conclusions: This study highlights differences in melanoma incidence and mortality from 1990-2017. Physicians involved in melanoma care should be aware of these changes in order to anticipate care needs.
Keywords: burden; global; incidence; melanoma; mortality.
© 2022, HMP Global. All rights reserved. Reproduction in whole or in part prohibited. Content may not be reproduced in any form without written permission. Rights, Permission, Reprint, and Translation information is available at www.hmpglobal.com.
Figures



Similar articles
-
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet Gastroenterol Hepatol. 2020 Jun;5(6):582-597. doi: 10.1016/S2468-1253(20)30007-8. Epub 2020 Apr 1. Lancet Gastroenterol Hepatol. 2020. PMID: 32246941 Free PMC article.
-
The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.PLoS Med. 2020 Jul 28;17(7):e1003198. doi: 10.1371/journal.pmed.1003198. eCollection 2020 Jul. PLoS Med. 2020. PMID: 32722671 Free PMC article.
-
Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.J Hematol Oncol. 2020 Jul 20;13(1):98. doi: 10.1186/s13045-020-00915-0. J Hematol Oncol. 2020. PMID: 32690044 Free PMC article.
-
Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017.Hum Reprod. 2021 Mar 18;36(4):1108-1119. doi: 10.1093/humrep/deaa371. Hum Reprod. 2021. PMID: 33501984 Free PMC article.
-
Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Respir Med. 2021 Sep;9(9):1030-1049. doi: 10.1016/S2213-2600(21)00164-8. Epub 2021 Aug 16. Lancet Respir Med. 2021. PMID: 34411511 Free PMC article.
Cited by
-
Considering Sun Safety Policies in the United States.Yale J Biol Med. 2023 Jun 30;96(2):251-255. doi: 10.59249/FMWG8617. eCollection 2023 Jun. Yale J Biol Med. 2023. PMID: 37396978 Free PMC article. Review.
-
Anticancer Effects of Fucoxanthin through Cell Cycle Arrest, Apoptosis Induction, Angiogenesis Inhibition, and Autophagy Modulation.Int J Mol Sci. 2022 Dec 17;23(24):16091. doi: 10.3390/ijms232416091. Int J Mol Sci. 2022. PMID: 36555740 Free PMC article. Review.
-
Moderating influences on parents' fatalistic beliefs about cancer and their association with sun safety behaviors among children of melanoma survivors: Implications for treatment.J Health Psychol. 2024 Apr;29(5):481-491. doi: 10.1177/13591053231209167. Epub 2023 Nov 16. J Health Psychol. 2024. PMID: 37968969 Free PMC article.
-
The Emerging Burden of Genetic Instability and Mutation in Melanoma: Role of Molecular Mechanisms.Cancers (Basel). 2022 Dec 15;14(24):6202. doi: 10.3390/cancers14246202. Cancers (Basel). 2022. PMID: 36551688 Free PMC article.
-
Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in Europe.JAMA Netw Open. 2024 Feb 5;7(2):e2356479. doi: 10.1001/jamanetworkopen.2023.56479. JAMA Netw Open. 2024. PMID: 38363565 Free PMC article.
References
-
- Guy GP, Ekwueme DU. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. PharmacoEconomics. Oct 2011;29(10):863-874. - PubMed
LinkOut - more resources
Full Text Sources